Boc-(�)-trans-4-(2,5-dichlorophenyl)pyrrolidine-3-carboxylic acid, 98.0%, 1g

tert-Butyl 4-(3-methoxybenzylamino)piperidine-1-carboxylate, 95.0%, 1g

3-Fluoro-5-nitrobenzoic acid, 95.0%, 10g

3,4-Difluoro-4'-(trans-4-pentylcyclohexyl)-1,1'-biphenyl, 95.0%, 25g

(2R)-2-{[(tert-butoxy)carbonyl]amino}non-8-enoic acid, 98%, 250mg

Reaktionsgefäß, DN100, 0,5 l, zylindr.,, gradu., Temp.-Vak.-Mantel, Entleerungsventil., 1 Stück

Cerium(III) chloride heptahydrate, 95.0%, 25g

(2E)-3-(2H-1,3-benzodioxol-5-yl)-1-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

6-Methoxy-3,4-dihydro-2H-benzo[b][1,4]oxazine, 95.0%, 250mg

3-Methoxybenzylamine, 97.0%, 100g

5-(chloromethyl)-1-methyl-1H-pyrazole hydrochloride, 95.0%, 5g

4-(4-Methylpiperazin-1-yl)phenylboronic acid, 95.0%, 1g

tert-Butyl 4-amino-3,3-difluoropyrrolidine-1-carboxylate, 95.0%, 10g